ASN001

Location:Home > Pipeline > ASN001

ASN001 is a non-selective beta-adrenergic receptor blocking agent indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma, is being developed by Auson for a new indication of infant hemangioma. Phase Ⅱ clinical trial is currently ongoing in China.